tbl12
Animal productexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT01096810)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tbl12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01302366 | Phase 2 | Feb 1, 2011 | New York University, Unicorn Pacific Corporation |
| NCT01096810 | Phase 2 | Sep 1, 2008 | Icahn School of Medicine at Mount Sinai, Unicorn Pacific Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Unicorn Pacific Corporation | For profit | 2 | 0 | 1 | 2008 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 1 | 1 | 2008 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1